AstraZeneca

AstraZeneca to stockpile drugs as Brexit 'safety net'
AstraZeneca to stockpile drugs as Brexit 'safety net'
Reuters
AstraZeneca
Brexit
UK
Europe
Flag link:
Hitting cancer early: AstraZeneca's bid to outmaneuver rivals
Hitting cancer early: AstraZeneca's bid to outmaneuver rivals
Yahoo/Reuters
AstraZeneca
Pascal Soriot
cancer
Imfinzi
Flag link:
AstraZeneca wins speedy approvals for cancer drugs in Japan
AstraZeneca wins speedy approvals for cancer drugs in Japan
Yahoo/Reuters
AstraZeneca
Japan
Imfinzi
Lynparza
Flag link:
AstraZeneca, Merck eye wider cancer drug use after study success
AstraZeneca, Merck eye wider cancer drug use after study success
Yahoo/Reuters
AstraZeneca
Merck
Lynparza
ovarian cancer
Flag link:
ADA: Lilly's Trulicity bests Novo's Victoza, AZ's Bydureon in real-world study
ADA: Lilly's Trulicity bests Novo's Victoza, AZ's Bydureon in real-world study
Fierce Pharma
Eli Lilly
Trulicity
diabetes
Novo Nordisk
Victoza
AstraZeneca
Bydureon
ADA
Flag link:
With an AstraZeneca cancer drug in one hand, $37M in the other, Shanghai’s Alpha Bio zooms into a PhII study
With an AstraZeneca cancer drug in one hand, $37M in the other, Shanghai’s Alpha Bio zooms into a PhII study
Endpoints
China
Alpha Bio
AstraZeneca
Flag link:
Eli Lilly and AstraZeneca Drop PhIII Alzheimer's Candidate – BACE Class May Be Done
Eli Lilly and AstraZeneca Drop PhIII Alzheimer's Candidate – BACE Class May Be Done
CP Wire
Eli Lilly
AstraZeneca
lanabecestat
Alzheimer's disease
BACE inhibitors
Flag link:
Eli Lilly and AstraZeneca Drop PhIII Alzheimer's Candidate – BACE Class May Be Done
Eli Lilly
AstraZeneca
lanabecestat
Alzheimer's disease
Flag link:
What to Expect for AstraZeneca in Fiscal 2018
What to Expect for AstraZeneca in Fiscal 2018
Market Realist
AstraZeneca
guidance
generics
Crestor
Japan
Europe
Flag link:
ASCO: AstraZeneca pioneer Lynparza scores with Zytiga combo in prostate cancer
ASCO: AstraZeneca pioneer Lynparza scores with Zytiga combo in prostate cancer
Fierce Pharma
AstraZeneca
Lynparza
prostate cancer
Flag link:
Prepping a drug launch, Zai Lab poaches AstraZeneca’s top cancer drug sales exec in China
Prepping a drug launch, Zai Lab poaches AstraZeneca’s top cancer drug sales exec in China
Endpoints
Zai Lab
AstraZeneca
China
Flag link:
AstraZeneca pressures fellow pharmas with vow to reveal doctor payments worldwide
AstraZeneca pressures fellow pharmas with vow to reveal doctor payments worldwide
Fierce Pharma
AstraZeneca
physicians
physician payments
Flag link:
ASCO: Merck and its new multibillion-dollar partners hone plans for marketing onslaught
ASCO: Merck and its new multibillion-dollar partners hone plans for marketing onslaught
Fierce Pharma
Merck
ASCO 2018
Keytruda
AstraZeneca
Eisai
Flag link:
AstraZeneca blames earnings nick on cost of biologics plant in Sweden
AstraZeneca blames earnings nick on cost of biologics plant in Sweden
Fierce Pharma
AstraZeneca
drug manufacturing
earnings
Sweden
Flag link:
AstraZeneca drug Fasenra fails to achieve main goal in COPD trial
AstraZeneca drug Fasenra fails to achieve main goal in COPD trial
Yahoo/Reuters
AstraZeneca
Fasenra
COPD
clinical trials
Flag link:
AstraZeneca Announces Positive Results for Imfinzi in Non-Small Cell Lung Cancer
AstraZeneca Announces Positive Results for Imfinzi in Non-Small Cell Lung Cancer
CP Wire
AstraZeneca
MedImmune
Imfinzi
non-small cell lung cancer
Flag link:
AstraZeneca Announces Positive Results for Imfinzi in Non-Small Cell Lung Cancer
AstraZeneca
Imfinzi
non-small cell lung cancer
Flag link:
Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca
Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca
CP Wire
Bicycle Therapeutics
AstraZeneca
Flag link:
Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca
Bicycle Therapeutics
AstraZeneca
Flag link:
AstraZeneca raising profile in Bay Area
AstraZeneca raising profile in Bay Area
Biopharma Dive
AstraZeneca
San Francisco
Flag link:

Pages